Arcutis Biotherapeutics, Inc. Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc.

ARQT

Kedudukan dalam Saham #3954
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to... Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes several other promising compounds. Among these is ARQ-154, a roflumilast foam applied topically, aimed at seborrheic dermatitis and scalp psoriasis. Furthermore, ARQ-252, a topical selective Janus kinase type 1 (JAK1) inhibitor, is under investigation for hand eczema and vitiligo. ARQ-255, a variation of ARQ-252 designed for deeper dermal absorption, is being explored for alopecia areata. Established in 2016, the company was initially named Arcutis, Inc. before changing to Arcutis Biotherapeutics, Inc. in October 2019. Its corporate headquarters are situated in Westlake Village, California.
Harga Saham
$32.70
Modal Pasaran
$4.11B
Perubahan (1 hari)
2.54%
Perubahan (1 tahun)
56.61%
Negara
US
Perdagangan Arcutis Biotherapeutics, Inc. (ARQT)

Kategori

Healthcare
Bilangan saham terbitan bagi Arcutis Biotherapeutics, Inc. (ARQT)
Bilangan saham terbitan setakat June 2026: 130.52M
Menurut laporan kewangan terkini dan harga saham Arcutis Biotherapeutics, Inc., bilangan saham terbitan semasa ialah 130.52M. Pada akhir December 2023, syarikat mempunyai 69.31M saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Arcutis Biotherapeutics, Inc. (ARQT) dari 2017 hingga 2026
Saham terbitan pada akhir setiap tahun
Tahun Saham Terbitan Ubah
2026 (TTM) 130.52M 7.91%
2024 120.96M 74.53%
2023 69.31M 25.94%
2022 55.03M 11.39%
2021 49.41M 38.52%
2020 35.67M -6.36%
2019 38.09M 5.11%
2018 36.24M 3,331.44%
2017 1.06M 0.00%
Saham terbitan bagi syarikat atau pesaing yang serupa
Syarikat Saham Terbitan Perbezaan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 94.53%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 203.40%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 266.92%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -52.36%
NL